welcome to oneFAPvoice- a positively charged Familial Adenomatous Polyposis community.
- join today!
Coxib-inhibition of Duodenal Polyp Growth in FAP
study id #: NCT00844727
condition: Duodenal Polyposis
Preliminary data indicate a protective effect on the development of duodenal polyps by coxib treatment. The hypothesis of the present study is that normal therapy doses of rofecoxib for 1 year would stop or reverse the development of premalignant adenomatous lesions in the duodenal mucosa of FAP patients.
start date: September 2003
estimated completion: April 2004
last updated: July 6, 2011
phase of development: Phase 2, Phase 3
size / enrollment: 38
Intervention Model: Parallel Assignment
Primary Purpose: Treatment
- FAP patient with previous colectomy and confirmed polyposis
- NSAID hypersensitivity
expertly curated content related to this topic
Freckles’ on his Retina Prompts a Man to Get Himself Tested for Colon Cancerhttps://img.washingtonpost.com/rw/2010-2...
Dietary Calcium Supplementation for Preventing Colorectal Cancer and Adenomatous PolypsBACKGROUND : Several dietary factors hav...
Trial In Pediatric Patients With Familial Adenomatous Polyposis (FAP)To test whether celecoxib can be used to...
Hereditary Colorectal Cancer Syndromes: American Society of Clinical Oncology Clinical Practice Guideline Endorsemen...Purpose: To provide recommendations on ...
Phase II Trial of the Gamma-Secretase Inhibitor PF-03084014 in Adults With Desmoid Tumors/Aggressive FibromatosisBackground: Desmoid tumors (also kn...
Ileal Pouch Anal Anastomosis: An Overview of Surgery, Recovery, and Achieving Postsurgical ContinenceIleal pouch anal anastomosis (IPAA) is a...
Macroscopic and Histologic Regression of Duodenal Polyposis with FOLFOX4 Chemotherapy for an Ileal Pouch Adenocarcin...Severe (stage IV) duodenal polyposis is ...